FactaeThe Factual News

Innate Pharma launches clinical trial for new cancer treatment

Innate Pharma announces the start of a phase 2 clinical trial for its lung cancer treatment.

Published 6sem1 sourceNotable
Lire en français
≈ 18s

The fact

This drug, developed with AstraZeneca, targets a specific protein in tumor cells.

First results are expected within 18 months.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
MarseilleWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on June 24, 2026
← Back to home
Discover

Read more

All marches →
marches

Innate Pharma reaches key milestone in treatment development

2sem · 1 sourcemarches

Innate Pharma to participate in a panel on bladder cancer

2sem · 1 sourcemarches

Innate Pharma: IPH5201 results to watch for funding implications

16sem · 1 sourcemarches

Innate Pharma draws close investor scrutiny

16sem · 1 sourcemarches

Innate Pharma: Gustave Roussy bets on NK cell therapies

5sem · 1 sourcemarches

Innate Pharma: takeover rumors intensify

1j · 1 source